5.88
price up icon9.50%   0.51
after-market Dopo l'orario di chiusura: 5.89 0.010 +0.17%
loading
Precedente Chiudi:
$5.37
Aprire:
$5.59
Volume 24 ore:
589.08K
Relative Volume:
0.46
Capitalizzazione di mercato:
$511.54M
Reddito:
-
Utile/perdita netta:
$-69.31M
Rapporto P/E:
-4.6299
EPS:
-1.27
Flusso di cassa netto:
$-62.80M
1 W Prestazione:
+9.91%
1M Prestazione:
+45.91%
6M Prestazione:
+17.84%
1 anno Prestazione:
+25.91%
Intervallo 1D:
Value
$5.59
$5.885
Intervallo di 1 settimana:
Value
$5.22
$5.885
Portata 52W:
Value
$2.215
$6.1856

Rezolute Inc Stock (RZLT) Company Profile

Name
Nome
Rezolute Inc
Name
Telefono
650-206-4507
Name
Indirizzo
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Name
Dipendente
20
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-11
Name
Ultimi documenti SEC
Name
RZLT's Discussions on Twitter

Confronta RZLT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RZLT
Rezolute Inc
5.88 467.17M 0 -69.31M -62.80M -1.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Rezolute Inc Stock (RZLT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-05 Iniziato Wedbush Outperform
2024-08-27 Iniziato Guggenheim Buy
2024-07-17 Iniziato BTIG Research Buy
2024-06-04 Iniziato Craig Hallum Buy
2024-04-09 Iniziato Maxim Group Buy
2022-08-02 Ripresa Canaccord Genuity Buy
2022-06-15 Iniziato Cantor Fitzgerald Overweight
2021-09-08 Iniziato ROTH Capital Buy
2021-05-27 Iniziato Oppenheimer Outperform
2021-05-25 Iniziato H.C. Wainwright Buy
Mostra tutto

Rezolute Inc Borsa (RZLT) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about Rezolute Inc. stockFree Bull & Bear Market Updates - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Rezolute Inc. stock priceOutstanding capital appreciation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Rezolute Inc. a good long term investmentFree Risk Assessment Services - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Rezolute Inc. Stock Analysis and ForecastConsistently profitable trades - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Rezolute to Participate in the BTIG Virtual Biotechnology Conference - The Manila Times

Jul 22, 2025
pulisher
Jul 18, 2025

Rezolute posts patient demographics poster for Phase 3 sunRIZE study - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Rezolute posts patient demographics poster for Phase 3 sunRIZE study By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Rezolute Completes Enrollment for Phase 3 sunRIZE Study - TipRanks

Jul 18, 2025
pulisher
Jul 17, 2025

Rezolute, Inc. shares rise 1.08% after-hours after registering a secondary offering of 1.3 million shares. - AInvest

Jul 17, 2025
pulisher
Jul 16, 2025

Craig-Hallum Maintains Rezolute(RZLT.US) With Buy Rating - 富途牛牛

Jul 16, 2025
pulisher
Jul 16, 2025

Craig-Hallum Reaffirms Their Buy Rating on Rezolute (RZLT) - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Rezolute Inc. stock price move sharplyPredictable Return Stock Picks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Rezolute Inc. stock attracts strong analyst attentionInstant Stock Updates - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Rezolute Inc. stock performs during market volatilityFree Trading Strategy Suggestions - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Rezolute Announces Presentation of Participant Baseline Data From Its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025) - 富途牛牛

Jul 12, 2025
pulisher
Jul 09, 2025

Rezolute, Inc. Announces Late-Breaking Presentation of Phase 3 Study Data for Ersodetug at ENDO 2025 - Quiver Quantitative

Jul 09, 2025
pulisher
Jul 09, 2025

Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025) - TradingView

Jul 09, 2025
pulisher
Jul 09, 2025

Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Rating of “Buy” from Analysts - Defense World

Jul 09, 2025
pulisher
Jul 01, 2025

Institutional investors must be pleased after a 11% gain last week that adds to Rezolute, Inc.'s (NASDAQ:RZLT) one-year returns - simplywall.st

Jul 01, 2025
pulisher
Jun 26, 2025

Rezolute Inc: chief medical officer Roberts buys $10939 in shares - Investing.com

Jun 26, 2025
pulisher
Jun 24, 2025

Rezolute CFO Evans buys $20,250 in company stock - Investing.com

Jun 24, 2025
pulisher
Jun 24, 2025

Rezolute CFO Evans buys $20,250 in company stock By Investing.com - Investing.com India

Jun 24, 2025
pulisher
Jun 23, 2025

Rezolute director Kim buys shares worth $3.99 million - Investing.com India

Jun 23, 2025
pulisher
Jun 14, 2025

Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Rezolute’s SWOT analysis: ersodetug trials boost stock amid clinical milestones - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Has $443,000 Stock Position in Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Two Sigma Investments LP Sells 12,118 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Squarepoint Ops LLC Sells 3,980 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Jun 10, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Decreases Stake in Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

69,724 Shares in Rezolute, Inc. (NASDAQ:RZLT) Bought by Ameriprise Financial Inc. - Defense World

Jun 06, 2025
pulisher
Jun 02, 2025

Rezolute, Inc. (NASDAQ:RZLT) is a favorite amongst institutional investors who own 77% - Yahoo Finance

Jun 02, 2025
pulisher
May 29, 2025

BTIG maintains $15 target on Rezolute stock following trial update - Investing.com Australia

May 29, 2025
pulisher
May 28, 2025

BTIG maintains $15 target on Rezolute stock following trial update By Investing.com - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Rezolute Announces Completion Of Enrollment In The Phase 3 Sunrize Study Of Ersodetug In Patients With Congenital Hyperinsulinism - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Rezolute complete enrollment in Phase 3 sunRIZE study of ersodetug - TipRanks

May 28, 2025
pulisher
May 28, 2025

Rezolute (RZLT) Completes Enrollment for Pivotal sunRIZE Study | - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Rezolute (RZLT) Completes Enrollment for Pivotal sunRIZE Study | RZLT Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism - The Manila Times

May 28, 2025

Rezolute Inc Azioni (RZLT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):